IBDEI0G9 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21835,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,21836,0)
 ;;=428.42^^140^1249^42
 ;;^UTILITY(U,$J,358.3,21836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21836,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,21836,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Chronic
 ;;^UTILITY(U,$J,358.3,21836,2)
 ;;= Heart Failure, Systolic & Diastolic, Chronic^328501
 ;;^UTILITY(U,$J,358.3,21837,0)
 ;;=428.43^^140^1249^41
 ;;^UTILITY(U,$J,358.3,21837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21837,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,21837,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute On Chronic
 ;;^UTILITY(U,$J,358.3,21837,2)
 ;;= Heart Failure, Systolic & Diastolic, Acute on Chronic^328502
 ;;^UTILITY(U,$J,358.3,21838,0)
 ;;=396.3^^140^1249^7
 ;;^UTILITY(U,$J,358.3,21838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21838,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,21838,1,5,0)
 ;;=5^Aortic And Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,21838,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,21839,0)
 ;;=414.3^^140^1249^17
 ;;^UTILITY(U,$J,358.3,21839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21839,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,21839,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,21839,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,21840,0)
 ;;=453.9^^140^1249^82
 ;;^UTILITY(U,$J,358.3,21840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21840,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,21840,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,21840,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,21841,0)
 ;;=453.89^^140^1249^1
 ;;^UTILITY(U,$J,358.3,21841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21841,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,21841,1,5,0)
 ;;=5^AC Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,21841,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,21842,0)
 ;;=453.79^^140^1249^27
 ;;^UTILITY(U,$J,358.3,21842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21842,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,21842,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,21842,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,21843,0)
 ;;=425.11^^140^1249^58
 ;;^UTILITY(U,$J,358.3,21843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21843,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,21843,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,21843,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,21844,0)
 ;;=425.18^^140^1249^63
 ;;^UTILITY(U,$J,358.3,21844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21844,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,21844,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,21844,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,21845,0)
 ;;=V12.55^^140^1249^53
 ;;^UTILITY(U,$J,358.3,21845,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21845,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,21845,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,21845,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,21846,0)
 ;;=414.4^^140^1249^16
 ;;^UTILITY(U,$J,358.3,21846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21846,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,21846,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,21846,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,21847,0)
 ;;=271.3^^140^1250^11
 ;;^UTILITY(U,$J,358.3,21847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21847,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,21847,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,21847,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,21848,0)
 ;;=611.1^^140^1250^16
 ;;^UTILITY(U,$J,358.3,21848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21848,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,21848,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,21848,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,21849,0)
 ;;=704.1^^140^1250^17
 ;;^UTILITY(U,$J,358.3,21849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21849,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,21849,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,21849,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,21850,0)
 ;;=251.2^^140^1250^29
 ;;^UTILITY(U,$J,358.3,21850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21850,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,21850,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,21850,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,21851,0)
 ;;=257.2^^140^1250^30
 ;;^UTILITY(U,$J,358.3,21851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21851,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,21851,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,21851,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,21852,0)
 ;;=253.2^^140^1250^33
 ;;^UTILITY(U,$J,358.3,21852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21852,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,21852,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,21852,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,21853,0)
 ;;=733.00^^140^1250^43
 ;;^UTILITY(U,$J,358.3,21853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21853,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,21853,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,21853,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,21854,0)
 ;;=278.00^^140^1250^40
 ;;^UTILITY(U,$J,358.3,21854,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21854,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,21854,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,21854,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,21855,0)
 ;;=278.01^^140^1250^39
 ;;^UTILITY(U,$J,358.3,21855,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21855,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,21855,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,21855,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,21856,0)
 ;;=250.80^^140^1250^5
 ;;^UTILITY(U,$J,358.3,21856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21856,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,21856,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,21856,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,21857,0)
 ;;=250.00^^140^1250^4
 ;;^UTILITY(U,$J,358.3,21857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21857,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,21857,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,21857,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,21858,0)
 ;;=250.40^^140^1250^6
 ;;^UTILITY(U,$J,358.3,21858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21858,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,21858,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,21858,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,21859,0)
 ;;=250.50^^140^1250^8
 ;;^UTILITY(U,$J,358.3,21859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21859,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,21859,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,21859,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,21860,0)
 ;;=250.60^^140^1250^7
 ;;^UTILITY(U,$J,358.3,21860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21860,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,21860,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,21860,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,21861,0)
 ;;=250.70^^140^1250^9
 ;;^UTILITY(U,$J,358.3,21861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21861,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,21861,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,21861,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,21862,0)
 ;;=250.01^^140^1250^3
 ;;^UTILITY(U,$J,358.3,21862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21862,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,21862,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,21862,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,21863,0)
 ;;=272.0^^140^1250^22
 ;;^UTILITY(U,$J,358.3,21863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21863,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,21863,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,21863,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,21864,0)
 ;;=272.1^^140^1250^27
 ;;^UTILITY(U,$J,358.3,21864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21864,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,21864,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,21864,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,21865,0)
 ;;=272.2^^140^1250^24
 ;;^UTILITY(U,$J,358.3,21865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21865,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,21865,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,21865,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,21866,0)
 ;;=275.42^^140^1250^21
 ;;^UTILITY(U,$J,358.3,21866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21866,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,21866,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,21866,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,21867,0)
 ;;=275.41^^140^1250^28
 ;;^UTILITY(U,$J,358.3,21867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21867,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,21867,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,21867,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,21868,0)
 ;;=276.7^^140^1250^23
 ;;^UTILITY(U,$J,358.3,21868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21868,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,21868,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,21868,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,21869,0)
 ;;=275.2^^140^1250^19
 ;;^UTILITY(U,$J,358.3,21869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21869,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,21869,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,21869,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,21870,0)
 ;;=276.0^^140^1250^25
 ;;^UTILITY(U,$J,358.3,21870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21870,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,21870,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,21870,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,21871,0)
 ;;=276.1^^140^1250^31
 ;;^UTILITY(U,$J,358.3,21871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21871,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,21871,1,5,0)
 ;;=5^Hyponatremia
